International Assets Investment Management LLC Invests $792,000 in Smith & Nephew plc (NYSE:SNN)

International Assets Investment Management LLC purchased a new position in Smith & Nephew plc (NYSE:SNN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 24,663 shares of the medical equipment provider's stock, valued at approximately $792,000.

A number of other large investors have also added to or reduced their stakes in SNN. Brandes Investment Partners LP grew its position in shares of Smith & Nephew by 20.5% in the 2nd quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider's stock worth $34,002,000 after acquiring an additional 233,293 shares in the last quarter. Bank of Montreal Can raised its position in Smith & Nephew by 355.8% during the second quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider's stock valued at $31,059,000 after buying an additional 964,762 shares during the period. Hsbc Holdings PLC lifted its stake in Smith & Nephew by 18.9% in the 2nd quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider's stock worth $13,607,000 after acquiring an additional 87,360 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider's stock worth $12,995,000 after acquiring an additional 193,046 shares during the period. Finally, Deprince Race & Zollo Inc. grew its stake in Smith & Nephew by 94.2% during the 2nd quarter. Deprince Race & Zollo Inc. now owns 239,245 shares of the medical equipment provider's stock valued at $5,928,000 after acquiring an additional 116,078 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Stock Down 4.2 %

Shares of NYSE SNN traded down $1.08 during trading hours on Wednesday, hitting $24.48. The stock had a trading volume of 1,117,760 shares, compared to its average volume of 861,991. The firm's 50-day moving average price is $29.62 and its two-hundred day moving average price is $27.84. Smith & Nephew plc has a 52 week low of $23.65 and a 52 week high of $31.72. The company has a current ratio of 2.51, a quick ratio of 1.11 and a debt-to-equity ratio of 0.63.

Analyst Ratings Changes

A number of research firms have recently issued reports on SNN. StockNews.com raised shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a research report on Monday, August 5th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday, November 1st. Finally, Berenberg Bank cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy".

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.